Cargando…
Comparison of rat and rabbit embryo–fetal developmental toxicity data for 379 pharmaceuticals: on the nature and severity of developmental effects
Regulatory non-clinical safety testing of human pharmaceuticals typically requires embryo–fetal developmental toxicity (EFDT) testing in two species (one rodent and one non-rodent). The question has been raised whether under some conditions EFDT testing could be limited to one species, or whether th...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865449/ https://www.ncbi.nlm.nih.gov/pubmed/27848393 http://dx.doi.org/10.1080/10408444.2016.1224807 |
_version_ | 1784655636609368064 |
---|---|
author | Theunissen, Peter T. Beken, Sonja Beyer, Bruce K. Breslin, William J. Cappon, Gregg D. Chen, Connie L. Chmielewski, Gary De Schaepdrijver, Luc Enright, Brian Foreman, Jennifer E. Harrouk, Wafa Hew, Kok-Wah Hoberman, Alan M. Hui, Julia Y. Knudsen, Thomas B. Laffan, Susan B. Makris, Susan L. Martin, Matt McNerney, Mary Ellen Siezen, Christine L. Stanislaus, Dinesh J. Stewart, Jane Thompson, Kary E. Tornesi, Belen Van der Laan, Jan Willem Weinbauer, Gerhard F. Wood, Sandra Piersma, Aldert H. |
author_facet | Theunissen, Peter T. Beken, Sonja Beyer, Bruce K. Breslin, William J. Cappon, Gregg D. Chen, Connie L. Chmielewski, Gary De Schaepdrijver, Luc Enright, Brian Foreman, Jennifer E. Harrouk, Wafa Hew, Kok-Wah Hoberman, Alan M. Hui, Julia Y. Knudsen, Thomas B. Laffan, Susan B. Makris, Susan L. Martin, Matt McNerney, Mary Ellen Siezen, Christine L. Stanislaus, Dinesh J. Stewart, Jane Thompson, Kary E. Tornesi, Belen Van der Laan, Jan Willem Weinbauer, Gerhard F. Wood, Sandra Piersma, Aldert H. |
author_sort | Theunissen, Peter T. |
collection | PubMed |
description | Regulatory non-clinical safety testing of human pharmaceuticals typically requires embryo–fetal developmental toxicity (EFDT) testing in two species (one rodent and one non-rodent). The question has been raised whether under some conditions EFDT testing could be limited to one species, or whether the testing in a second species could be decided on a case-by-case basis. As part of a consortium initiative, we built and queried a database of 379 compounds with EFDT studies (in both rat and rabbit animal models) conducted for marketed and non-marketed pharmaceuticals for their potential for adverse developmental and maternal outcomes, including EFDT incidence and the nature and severity of adverse findings. Manifestation of EFDT in either one or both species was demonstrated for 282 compounds (74%). EFDT was detected in only one species (rat or rabbit) in almost a third (31%, 118 compounds), with 58% (68 compounds) of rat studies and 42% (50 compounds) of rabbit studies identifying an EFDT signal. For 24 compounds (6%), fetal malformations were observed in one species (rat or rabbit) in the absence of any EFDT in the second species. In general, growth retardation, fetal variations, and malformations were more prominent in the rat, whereas embryo–fetal death was observed more often in the rabbit. Discordance across species may be attributed to factors such as maternal toxicity, study design differences, pharmacokinetic differences, and pharmacologic relevance of species. The current analysis suggests that in general both species are equally sensitive on the basis of an overall EFDT LOAEL comparison, but selective EFDT toxicity in one species is not uncommon. Also, there appear to be species differences in the prevalence of various EFDT manifestations (i.e. embryo–fetal death, growth retardation, and dysmorphogenesis) between rat and rabbit, suggesting that the use of both species has a higher probability of detecting developmental toxicants than either one alone. |
format | Online Article Text |
id | pubmed-8865449 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
record_format | MEDLINE/PubMed |
spelling | pubmed-88654492022-02-23 Comparison of rat and rabbit embryo–fetal developmental toxicity data for 379 pharmaceuticals: on the nature and severity of developmental effects Theunissen, Peter T. Beken, Sonja Beyer, Bruce K. Breslin, William J. Cappon, Gregg D. Chen, Connie L. Chmielewski, Gary De Schaepdrijver, Luc Enright, Brian Foreman, Jennifer E. Harrouk, Wafa Hew, Kok-Wah Hoberman, Alan M. Hui, Julia Y. Knudsen, Thomas B. Laffan, Susan B. Makris, Susan L. Martin, Matt McNerney, Mary Ellen Siezen, Christine L. Stanislaus, Dinesh J. Stewart, Jane Thompson, Kary E. Tornesi, Belen Van der Laan, Jan Willem Weinbauer, Gerhard F. Wood, Sandra Piersma, Aldert H. Crit Rev Toxicol Article Regulatory non-clinical safety testing of human pharmaceuticals typically requires embryo–fetal developmental toxicity (EFDT) testing in two species (one rodent and one non-rodent). The question has been raised whether under some conditions EFDT testing could be limited to one species, or whether the testing in a second species could be decided on a case-by-case basis. As part of a consortium initiative, we built and queried a database of 379 compounds with EFDT studies (in both rat and rabbit animal models) conducted for marketed and non-marketed pharmaceuticals for their potential for adverse developmental and maternal outcomes, including EFDT incidence and the nature and severity of adverse findings. Manifestation of EFDT in either one or both species was demonstrated for 282 compounds (74%). EFDT was detected in only one species (rat or rabbit) in almost a third (31%, 118 compounds), with 58% (68 compounds) of rat studies and 42% (50 compounds) of rabbit studies identifying an EFDT signal. For 24 compounds (6%), fetal malformations were observed in one species (rat or rabbit) in the absence of any EFDT in the second species. In general, growth retardation, fetal variations, and malformations were more prominent in the rat, whereas embryo–fetal death was observed more often in the rabbit. Discordance across species may be attributed to factors such as maternal toxicity, study design differences, pharmacokinetic differences, and pharmacologic relevance of species. The current analysis suggests that in general both species are equally sensitive on the basis of an overall EFDT LOAEL comparison, but selective EFDT toxicity in one species is not uncommon. Also, there appear to be species differences in the prevalence of various EFDT manifestations (i.e. embryo–fetal death, growth retardation, and dysmorphogenesis) between rat and rabbit, suggesting that the use of both species has a higher probability of detecting developmental toxicants than either one alone. 2016-11 2016-10-19 /pmc/articles/PMC8865449/ /pubmed/27848393 http://dx.doi.org/10.1080/10408444.2016.1224807 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. |
spellingShingle | Article Theunissen, Peter T. Beken, Sonja Beyer, Bruce K. Breslin, William J. Cappon, Gregg D. Chen, Connie L. Chmielewski, Gary De Schaepdrijver, Luc Enright, Brian Foreman, Jennifer E. Harrouk, Wafa Hew, Kok-Wah Hoberman, Alan M. Hui, Julia Y. Knudsen, Thomas B. Laffan, Susan B. Makris, Susan L. Martin, Matt McNerney, Mary Ellen Siezen, Christine L. Stanislaus, Dinesh J. Stewart, Jane Thompson, Kary E. Tornesi, Belen Van der Laan, Jan Willem Weinbauer, Gerhard F. Wood, Sandra Piersma, Aldert H. Comparison of rat and rabbit embryo–fetal developmental toxicity data for 379 pharmaceuticals: on the nature and severity of developmental effects |
title | Comparison of rat and rabbit embryo–fetal developmental toxicity data for 379 pharmaceuticals: on the nature and severity of developmental effects |
title_full | Comparison of rat and rabbit embryo–fetal developmental toxicity data for 379 pharmaceuticals: on the nature and severity of developmental effects |
title_fullStr | Comparison of rat and rabbit embryo–fetal developmental toxicity data for 379 pharmaceuticals: on the nature and severity of developmental effects |
title_full_unstemmed | Comparison of rat and rabbit embryo–fetal developmental toxicity data for 379 pharmaceuticals: on the nature and severity of developmental effects |
title_short | Comparison of rat and rabbit embryo–fetal developmental toxicity data for 379 pharmaceuticals: on the nature and severity of developmental effects |
title_sort | comparison of rat and rabbit embryo–fetal developmental toxicity data for 379 pharmaceuticals: on the nature and severity of developmental effects |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865449/ https://www.ncbi.nlm.nih.gov/pubmed/27848393 http://dx.doi.org/10.1080/10408444.2016.1224807 |
work_keys_str_mv | AT theunissenpetert comparisonofratandrabbitembryofetaldevelopmentaltoxicitydatafor379pharmaceuticalsonthenatureandseverityofdevelopmentaleffects AT bekensonja comparisonofratandrabbitembryofetaldevelopmentaltoxicitydatafor379pharmaceuticalsonthenatureandseverityofdevelopmentaleffects AT beyerbrucek comparisonofratandrabbitembryofetaldevelopmentaltoxicitydatafor379pharmaceuticalsonthenatureandseverityofdevelopmentaleffects AT breslinwilliamj comparisonofratandrabbitembryofetaldevelopmentaltoxicitydatafor379pharmaceuticalsonthenatureandseverityofdevelopmentaleffects AT cappongreggd comparisonofratandrabbitembryofetaldevelopmentaltoxicitydatafor379pharmaceuticalsonthenatureandseverityofdevelopmentaleffects AT chenconniel comparisonofratandrabbitembryofetaldevelopmentaltoxicitydatafor379pharmaceuticalsonthenatureandseverityofdevelopmentaleffects AT chmielewskigary comparisonofratandrabbitembryofetaldevelopmentaltoxicitydatafor379pharmaceuticalsonthenatureandseverityofdevelopmentaleffects AT deschaepdrijverluc comparisonofratandrabbitembryofetaldevelopmentaltoxicitydatafor379pharmaceuticalsonthenatureandseverityofdevelopmentaleffects AT enrightbrian comparisonofratandrabbitembryofetaldevelopmentaltoxicitydatafor379pharmaceuticalsonthenatureandseverityofdevelopmentaleffects AT foremanjennifere comparisonofratandrabbitembryofetaldevelopmentaltoxicitydatafor379pharmaceuticalsonthenatureandseverityofdevelopmentaleffects AT harroukwafa comparisonofratandrabbitembryofetaldevelopmentaltoxicitydatafor379pharmaceuticalsonthenatureandseverityofdevelopmentaleffects AT hewkokwah comparisonofratandrabbitembryofetaldevelopmentaltoxicitydatafor379pharmaceuticalsonthenatureandseverityofdevelopmentaleffects AT hobermanalanm comparisonofratandrabbitembryofetaldevelopmentaltoxicitydatafor379pharmaceuticalsonthenatureandseverityofdevelopmentaleffects AT huijuliay comparisonofratandrabbitembryofetaldevelopmentaltoxicitydatafor379pharmaceuticalsonthenatureandseverityofdevelopmentaleffects AT knudsenthomasb comparisonofratandrabbitembryofetaldevelopmentaltoxicitydatafor379pharmaceuticalsonthenatureandseverityofdevelopmentaleffects AT laffansusanb comparisonofratandrabbitembryofetaldevelopmentaltoxicitydatafor379pharmaceuticalsonthenatureandseverityofdevelopmentaleffects AT makrissusanl comparisonofratandrabbitembryofetaldevelopmentaltoxicitydatafor379pharmaceuticalsonthenatureandseverityofdevelopmentaleffects AT martinmatt comparisonofratandrabbitembryofetaldevelopmentaltoxicitydatafor379pharmaceuticalsonthenatureandseverityofdevelopmentaleffects AT mcnerneymaryellen comparisonofratandrabbitembryofetaldevelopmentaltoxicitydatafor379pharmaceuticalsonthenatureandseverityofdevelopmentaleffects AT siezenchristinel comparisonofratandrabbitembryofetaldevelopmentaltoxicitydatafor379pharmaceuticalsonthenatureandseverityofdevelopmentaleffects AT stanislausdineshj comparisonofratandrabbitembryofetaldevelopmentaltoxicitydatafor379pharmaceuticalsonthenatureandseverityofdevelopmentaleffects AT stewartjane comparisonofratandrabbitembryofetaldevelopmentaltoxicitydatafor379pharmaceuticalsonthenatureandseverityofdevelopmentaleffects AT thompsonkarye comparisonofratandrabbitembryofetaldevelopmentaltoxicitydatafor379pharmaceuticalsonthenatureandseverityofdevelopmentaleffects AT tornesibelen comparisonofratandrabbitembryofetaldevelopmentaltoxicitydatafor379pharmaceuticalsonthenatureandseverityofdevelopmentaleffects AT vanderlaanjanwillem comparisonofratandrabbitembryofetaldevelopmentaltoxicitydatafor379pharmaceuticalsonthenatureandseverityofdevelopmentaleffects AT weinbauergerhardf comparisonofratandrabbitembryofetaldevelopmentaltoxicitydatafor379pharmaceuticalsonthenatureandseverityofdevelopmentaleffects AT woodsandra comparisonofratandrabbitembryofetaldevelopmentaltoxicitydatafor379pharmaceuticalsonthenatureandseverityofdevelopmentaleffects AT piersmaalderth comparisonofratandrabbitembryofetaldevelopmentaltoxicitydatafor379pharmaceuticalsonthenatureandseverityofdevelopmentaleffects |